Literature DB >> 7964973

Matrix degrading metalloproteinases.

B W Ennis1, L M Matrisian.   

Abstract

Matrix degrading metalloproteinases are enzymes that degrade proteins in tissue extracellular matrices. These proteinases exhibit specific, well defined properties that allow them to be classified into a family of enzymes. They are secreted by various cell types as the cells effect their surrounding extracellular matrix. Such effects occur during normal physiologic tissue remodeling but also during pathologic processes such as tumor cell invasion and metastases. Currently there are seven proteases classified as members of the matrix metalloproteinase family and there are two putative members. Direct correlations can be made between the matrix metalloproteinases and normal tissue functions such as bone remodeling, uterine and mammary gland function and ovulation. The matrix metalloproteinases are also strongly associated with cancer progression in that they function to degrade epithelial basement membrane and stromal matrices in many different malignancies including brain tumors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964973     DOI: 10.1007/BF01050416

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  34 in total

1.  The presence and possible functions of the matrix metalloproteinase collagenase activator protein in developing enamel matrix.

Authors:  P K DenBesten; L M Heffernan; B V Treadwell; B J Awbrey
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

2.  Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells.

Authors:  Y A De Clerck; T D Yean; B J Ratzkin; H S Lu; K E Langley
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

3.  Protease production by cultured microglia: substrate gel analysis and immobilized matrix degradation.

Authors:  C A Colton; J E Keri; W T Chen; W L Monsky
Journal:  J Neurosci Res       Date:  1993-06-15       Impact factor: 4.164

4.  Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors.

Authors:  J S Rao; P A Steck; S Mohanam; W G Stetler-Stevenson; L A Liotta; R Sawaya
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

5.  Purification and properties of a small latent matrix metalloproteinase of the rat uterus.

Authors:  J F Woessner; C J Taplin
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

6.  Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase.

Authors:  S D Shapiro; G L Griffin; D J Gilbert; N A Jenkins; N G Copeland; H G Welgus; R M Senior; T J Ley
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

7.  Purification and characterization of a two-chain form of tissue inhibitor of metalloproteinases (TIMP) type 2 and a low molecular weight TIMP-like protein.

Authors:  K Miyazaki; K Funahashi; Y Numata; N Koshikawa; K Akaogi; Y Kikkawa; H Yasumitsu; M Umeda
Journal:  J Biol Chem       Date:  1993-07-05       Impact factor: 5.157

8.  Expressions of matrilysin and stromelysin in human glioma cells.

Authors:  A Nakano; E Tani; K Miyazaki; J Furuyama; T Matsumoto
Journal:  Biochem Biophys Res Commun       Date:  1993-05-14       Impact factor: 3.575

9.  Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro.

Authors:  C M Alexander; Z Werb
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

10.  Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture.

Authors:  R S Talhouk; J R Chin; E N Unemori; Z Werb; M J Bissell
Journal:  Development       Date:  1991-06       Impact factor: 6.868

View more
  14 in total

1.  Connecting secretome to hematopoietic stem cell phenotype shifts in an engineered bone marrow niche.

Authors:  Aidan E Gilchrist; Brendan A C Harley
Journal:  Integr Biol (Camb)       Date:  2020-07-10       Impact factor: 2.192

2.  Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer.

Authors:  Marcus Langenskiöld; Lena Holmdahl; Peter Falk; Marie-Louise Ivarsson
Journal:  Int J Colorectal Dis       Date:  2004-12-08       Impact factor: 2.571

3.  Medulloblastoma displays distinct regional matrix metalloprotease expression.

Authors:  G H Vince; C Herbold; R Klein; J Kühl; T Pietsch; S Franz; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

4.  MMP-9 expression in meningiomas: a prognostic marker for recurrence risk?

Authors:  V Barresi; E Vitarelli; G Tuccari; G Barresi
Journal:  J Neurooncol       Date:  2010-07-21       Impact factor: 4.130

5.  Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40).

Authors:  J R Backstrom; G P Lim; M J Cullen; Z A Tökés
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

6.  Evolution of cell motility in an individual-based model of tumour growth.

Authors:  P Gerlee; A R A Anderson
Journal:  J Theor Biol       Date:  2009-03-12       Impact factor: 2.691

7.  Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI.

Authors:  Robert J Harris; Susan Y Bookheimer; Timothy F Cloughesy; Hyun J Kim; Whitney B Pope; Albert Lai; Phioanh L Nghiemphu; Linda M Liau; Benjamin M Ellingson
Journal:  J Neurooncol       Date:  2014-01       Impact factor: 4.130

8.  A hybrid cellular automaton model of clonal evolution in cancer: the emergence of the glycolytic phenotype.

Authors:  P Gerlee; A R A Anderson
Journal:  J Theor Biol       Date:  2007-11-04       Impact factor: 2.691

9.  Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma.

Authors:  Piotr Daniel; Malgorzata Wagrowska-Danilewicz; Marian Danilewicz; Olga Stasikowska; Ewa Malecka-Panas
Journal:  Int J Colorectal Dis       Date:  2007-03-30       Impact factor: 2.571

10.  Expression of proteinases and inhibitors in human breast cancer progression and survival.

Authors:  E A Baker; T J Stephenson; M W R Reed; N J Brown
Journal:  Mol Pathol       Date:  2002-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.